The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical characteristics and treatment outcome of patients with advanced non-small-cell lung cancer (NSCLC) and FGFR fusions.
 
Heather Scharpenseel
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen
 
Andreas Stickelmann
No Relationships to Disclose
 
Janna Siemanowski
Speakers' Bureau - AstraZeneca; Biocartis; Merck (I); Molecular Health; Targos
 
Florian Malchers
No Relationships to Disclose
 
Matthias Scheffler
Honoraria - Amgen; AstraZeneca/Daiichi Sankyo; Boehringer Ingelheim; Novartis; Pfizer; Roche; Siemens Healthineers; Takeda
Consulting or Advisory Role - Amgen; Boehringer Ingelheim; Janssen Oncology; Novartis; Pfizer; Roche; Sanofi/Aventis; Takeda
Research Funding - Amgen (Inst); BMS GmbH & Co. KG (Inst); Dracen (Inst); Janssen (Inst); Novartis (Inst); Siemens Healthineers (Inst)
Travel, Accommodations, Expenses - Amgen; Boehringer Ingelheim; Janssen; Pfizer
 
Axel Hillmer
Research Funding - Dracen
 
Sonja Meemboor
No Relationships to Disclose
 
Sabine Merkelbach-Bruse
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Janssen; Novartis; Pfizer; Roche Pharma AG
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Novartis
 
Andreas H. Scheel
No Relationships to Disclose
 
Richard Riedel
Consulting or Advisory Role - Boehringer Ingelheim; Novartis
Travel, Accommodations, Expenses - Lilly; Loxo
 
Sebastian Yves Friedrich Michels
Honoraria - AstraZeneca; Janssen Oncology; Merck KGaA; Novartis; Pfizer; Takeda
Consulting or Advisory Role - Boehringer Ingelheim; Pfizer; Roche Pharma AG
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Novartis
 
Anna Eisert
Honoraria - Amgen; AstraZeneca; Merck
Consulting or Advisory Role - Merck
Travel, Accommodations, Expenses - Takeda
 
Rieke Nila Fischer
Consulting or Advisory Role - Bristol-Myers Squibb/Medarex
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Janssen
 
Marlene Brodersen
No Relationships to Disclose
 
Roman K. Thomas
Consulting or Advisory Role - NEO New Oncology; PearlRiver Bio
Other Relationship - NEO New Oncology; PearlRiver Bio
 
Reinhard Büttner
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Illumina; MSD
Expert Testimony - MSD
Other Relationship - Gnothis
 
Ullrich Graeven
Stock and Other Ownership Interests - Biontech
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celltrion; Fujifilm; MSD Oncology; Novartis; Sanofi Aventis GmbH
Consulting or Advisory Role - Amgen; MSD Oncology
Research Funding - Ipsen (Inst); Macrogenics (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; GlaxoSmithKline
 
Nils Kosse
No Relationships to Disclose
 
Lucia Nogova
Honoraria - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Novartis; Pfizer; Roche; Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Dracen (Inst); Janssen (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Celgene; Janssen; Novartis; Pfizer
 
Juergen Wolf
Honoraria - Abbvie; Amgen; AstraZeneca; Bayer; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Janssen; Lilly; Loxo; Loxo/Lilly; Merck; Mirati Therapeutics; MSD; Novartis; Nuvalent, Inc.; Pfizer; Roche; Seagen; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Amgen; AstraZeneca; Bayer; Blueprint Medicines; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Ignyta; Janssen; Lilly; Loxo/Lilly; Merck; Mirati Therapeutics; Novartis; Nuvalent, Inc.; Pfizer; Roche; Seagen; Takeda
Research Funding - Bristol-Myers Squibb; Janssen; Novartis; Pfizer
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Janssen; Merck; Mirati Therapeutics; Novartis; Pfizer; Sanofi